Literature DB >> 34717821

Predicting diabetes risk in diverse populations: what next?

Josep M Mercader1, Maggie C Y Ng2, Alisa K Manning3, Stephen S Rich4.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34717821      PMCID： PMC8865284          DOI： 10.1016/S2213-8587(21)00287-4

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   44.867


× No keyword cloud information.
  7 in total

Review 1.  Clinical use of current polygenic risk scores may exacerbate health disparities.

Authors:  Alicia R Martin; Masahiro Kanai; Yoichiro Kamatani; Yukinori Okada; Benjamin M Neale; Mark J Daly
Journal:  Nat Genet       Date:  2019-03-29       Impact factor: 38.330

2.  Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score.

Authors:  Suna Onengut-Gumuscu; Wei-Min Chen; Catherine C Robertson; Jessica K Bonnie; Emily Farber; Zhennan Zhu; Jorge R Oksenberg; Steven R Brant; S Louis Bridges; Jeffrey C Edberg; Robert P Kimberly; Peter K Gregersen; Marian J Rewers; Andrea K Steck; Mary H Black; Dana Dabelea; Catherine Pihoker; Mark A Atkinson; Lynne E Wagenknecht; Jasmin Divers; Ronny A Bell; Henry A Erlich; Patrick Concannon; Stephen S Rich
Journal:  Diabetes Care       Date:  2019-01-18       Impact factor: 19.112

3.  Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.

Authors:  Nina Mars; Jukka T Koskela; Pietari Ripatti; Tuomo T J Kiiskinen; Aki S Havulinna; Joni V Lindbohm; Ari Ahola-Olli; Mitja Kurki; Juha Karjalainen; Priit Palta; Benjamin M Neale; Mark Daly; Veikko Salomaa; Aarno Palotie; Elisabeth Widén; Samuli Ripatti
Journal:  Nat Med       Date:  2020-04-07       Impact factor: 53.440

4.  Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes.

Authors:  Catherine C Robertson; Jamie R J Inshaw; Suna Onengut-Gumuscu; Wei-Min Chen; David Flores Santa Cruz; Hanzhi Yang; Antony J Cutler; Daniel J M Crouch; Emily Farber; S Louis Bridges; Jeffrey C Edberg; Robert P Kimberly; Jane H Buckner; Panos Deloukas; Jasmin Divers; Dana Dabelea; Jean M Lawrence; Santica Marcovina; Amy S Shah; Carla J Greenbaum; Mark A Atkinson; Peter K Gregersen; Jorge R Oksenberg; Flemming Pociot; Marian J Rewers; Andrea K Steck; David B Dunger; Linda S Wicker; Patrick Concannon; John A Todd; Stephen S Rich
Journal:  Nat Genet       Date:  2021-06-14       Impact factor: 41.307

5.  A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults.

Authors:  Richard A Oram; Kashyap Patel; Anita Hill; Beverley Shields; Timothy J McDonald; Angus Jones; Andrew T Hattersley; Michael N Weedon
Journal:  Diabetes Care       Date:  2015-11-17       Impact factor: 19.112

Review 6.  Primary prevention of beta-cell autoimmunity and type 1 diabetes - The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives.

Authors:  A G Ziegler; T Danne; D B Dunger; R Berner; R Puff; W Kiess; G Agiostratidou; J A Todd; E Bonifacio
Journal:  Mol Metab       Date:  2016-02-22       Impact factor: 7.422

7.  Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis.

Authors:  Miriam S Udler; Jaegil Kim; Marcin von Grotthuss; Sílvia Bonàs-Guarch; Joanne B Cole; Joshua Chiou; Michael Boehnke; Markku Laakso; Gil Atzmon; Benjamin Glaser; Josep M Mercader; Kyle Gaulton; Jason Flannick; Gad Getz; Jose C Florez
Journal:  PLoS Med       Date:  2018-09-21       Impact factor: 11.069
  7 in total
  1 in total

Review 1.  On the Verge of Precision Medicine in Diabetes.

Authors:  Josephine H Li; Jose C Florez
Journal:  Drugs       Date:  2022-09-19       Impact factor: 11.431
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.